Roles and responsibilities for clinical trial safety reporting of significant safety issues and urgent safety measures

Information

Type

Page

Regulated products

Medical Devices

Topics

Clinical Trials, Safety

Published

January 8, 2024

Last updated

January 9, 2024

Description

Summarises the roles and responsibilities of key stakeholders in clinical trial safety reporting of significant safety issues (SSIs) and urgent safety measures (USMs).

Organization

Country / Region

Australia

License

Other (Non-Commercial)

Feedback

Suggest an improvement to this page

Actions

Social networks

Embed